World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
108
Citations
38658
World Ranking
986
National Ranking
601

Medicine

D-Index
110
Citations
39619
World Ranking
5618
National Ranking
3022

Kathleen R. Lamborn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kathleen R. Lamborn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 316 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kathleen R. Lamborn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kathleen R. Lamborn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 1984 - Fellow of the American Statistical Association (ASA)

Overview

Kathleen R. Lamborn is affiliated with the University of California, San Francisco in the United States. Their research spans several fields including medicine, biochemistry, genetics, molecular biology, and mathematics, reflecting an interdisciplinary approach. Within these fields, the scientist has contributed specifically to genetics, cancer research, and modeling and simulation.

The main topics of their work concentrate on glioma diagnosis and treatment, cancer genomics and diagnostics, and mathematical biology related to tumor growth. These focus areas illustrate a blend of clinical and computational strategies aimed at understanding and addressing cancer progression.

Among their recent scholarly contributions is the paper titled "Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02", published in Neuro-Oncology Advances in 2020. This work has been cited 21 times, highlighting engagement within the oncology research community.

Frequent co-authors who have collaborated with Kathleen R. Lamborn include:

  • Huanwen Chen
  • John G. Kuhn
  • Lauren E. Abrey
  • Lisa M. DeAngelis
  • Frank S. Lieberman

The pattern of publication venues shows a focus on Neuro-Oncology Advances, where the scientist has published at least one paper.

Kathleen R. Lamborn was awarded the title of Fellow of the American Statistical Association (ASA) in 1984. This recognition indicates a significant contribution to the field of statistical science.

Best Publications

  • Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy

  • Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

    Justin S. Smith;Edward F. Chang;Kathleen R. Lamborn;Susan M. Chang

  • Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

    Yu Liang;Maximilian Diehn;Nathan Watson;Andrew W. Bollen

  • Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.

    G E Keles;K R Lamborn;M S Berger

  • Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis

    Kathleen R. Lamborn;Susan M. Chang;Michael D. Prados

  • Seizure characteristics and control following resection in 332 patients with low-grade gliomas

    Edward F. Chang;Matthew B. Potts;G. Evren Keles;Kathleen R. Lamborn

  • Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib

    Daphne A. Haas-Kogan;Michael D. Prados;Tarik Tihan;David A. Eberhard

  • Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

    Penny K. Sneed;Paul R. Stauffer;Michael W. McDermott;Chris J. Diederich

  • Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

    Penny K Sneed;Kathleen R Lamborn;Julie M Forstner;Michael W McDermott

  • Intraoperative subcortical stimulation mapping for hemispherical perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients.

    G Evren Keles;David A Lundin;Kathleen R Lamborn;Edward F Chang

  • Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

    Patrick Y. Wen;W. K Alfred Yung;Kathleen R. Lamborn;Patricia L. Dahia

  • Transsphenoidal Microsurgery for Growth Hormone-Secreting Pituitary Adenomas: Initial Outcome and Long-Term Results

    A Abosch;J B Tyrrell;K R Lamborn;L T Hannegan

  • Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.

    Susan M. Chang;Patrick Wen;Timothy Cloughesy;Harry Greenberg

  • Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

    Kathleen R. Lamborn;W. K.Alfred Yung;Susan M. Chang;Patrick Y. Wen

  • Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.

    Gary D. Hammer;J. Blake Tyrrell;Kathleen R. Lamborn;Carol B. Applebury

  • Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

    Michael D. Prados;Susan M. Chang;Nicholas Butowski;Rebecca DeBoer

  • Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

    Osama O. Gaber;M. Roy First;Raymond J. Tesi;Robert S. Gaston

  • A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

    Jeffrey J. Raizer;Lauren E. Abrey;Andrew B. Lassman;Susan M. Chang

  • Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.

    Martha L. Simmons;Kathleen R. Lamborn;Michelle Takahashi;Pengchin Chen

  • Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

    Igor Vivanco;H. Ian Robins;Daniel Rohle;Carl Campos

Frequent Co-Authors

Michael D. Prados
Michael D. Prados University of California, San Francisco
Susan M. Chang
Susan M. Chang University of California, San Francisco
William M. Wara
William M. Wara Kaiser Permanente
Mitchel S. Berger
Mitchel S. Berger University of California, San Francisco
David A. Larson
David A. Larson University of California, San Francisco
Penny K. Sneed
Penny K. Sneed University of California, San Francisco
Michael W. McDermott
Michael W. McDermott University of California, San Francisco
Patrick Y. Wen
Patrick Y. Wen Harvard University
Timothy F. Cloughesy
Timothy F. Cloughesy University of California, Los Angeles
Lisa M. DeAngelis
Lisa M. DeAngelis Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or complementary healthcare degrees can open up diverse career opportunities for those interested in the medical field. Many students consider flexible, affordable online programs as a pathway to start or advance their careers without putting their lives on hold.

For those drawn to the business side of healthcare, researching healthcare administration degree cost can help you find programs that fit your budget while building valuable leadership skills. If you’re aiming higher, the cheapest mha programs online healthcare provide opportunities for advanced credentials in administration and management roles.

Clinical professionals interested in leadership or specialized practice might explore the best dnp programs online. These programs offer flexibility and advanced education for nurses wanting to reach the top of their field. Similarly, those looking to become pharmacists can benefit from the convenience and affordability of an online pharmacy degree.

Each of these online pathways provides unique benefits and can be a smart stepping stone toward a rewarding career in healthcare.

Best Scientists Citing Kathleen R. Lamborn

Trending Scientists

Recently Published Articles